GenSight Biologics Reports Topline Results from REFLECT Phase III Clinical Trial, Confirming LUMEVOQ® Efficacy Including Better Efficacy with Bilateral Treatment

UMDF Mitochondrial Medicine 2021 – virtual

Clinical Operations Strategy Meeting online 2021

BIO US 2021 – Digital

GenSight Biologics Announces Publication of Indirect Comparison Showing Treatment Effect of LUMEVOQ® versus Natural History in Frontiers in Neurology

Advanced Therapies – Virtual

GenSight Biologics Provides 2021 Operations Update in the Context of COVID-19

GenSight Biologics Announces Publication of Results from the REALITY LHON Natural History Study in the Journal Eye

2021 ARVO Annual Meeting, virtual

BioEurope Spring – virtual